Dr. Mink Chawla

So we are very interested in the fact that many things that cause problems are attracted to the inner blood vessel wall, like oxidized LDL, advanced glycolysis, endotoxics. We think, and we're getting to do some initial research here, that these things are attracted to the blood vessel wall. So if I offer up to these gamish people,

So we are very interested in the fact that many things that cause problems are attracted to the inner blood vessel wall, like oxidized LDL, advanced glycolysis, endotoxics. We think, and we're getting to do some initial research here, that these things are attracted to the blood vessel wall. So if I offer up to these gamish people,

So we are very interested in the fact that many things that cause problems are attracted to the inner blood vessel wall, like oxidized LDL, advanced glycolysis, endotoxics. We think, and we're getting to do some initial research here, that these things are attracted to the blood vessel wall. So if I offer up to these gamish people,

40 meter square surface to go get lodged into, we think we can make a huge impact to remove that. I also think that to the degree that people have chronic antigenemia from whatever, if we, whether it's a chronic viremia or something they have, this could impact them in a very positive way.

40 meter square surface to go get lodged into, we think we can make a huge impact to remove that. I also think that to the degree that people have chronic antigenemia from whatever, if we, whether it's a chronic viremia or something they have, this could impact them in a very positive way.

40 meter square surface to go get lodged into, we think we can make a huge impact to remove that. I also think that to the degree that people have chronic antigenemia from whatever, if we, whether it's a chronic viremia or something they have, this could impact them in a very positive way.

So the most important thing that we kind of believe generically in medicine is what is the risk to the patient before you talk about the benefit? And this device has been in over 2,500 patients now. It's very safe. It's as safe as a dialysis procedure. So when you have a nice safety profile, you can move from the sickest patients in the intensive care unit, which is what we did for COVID.

So the most important thing that we kind of believe generically in medicine is what is the risk to the patient before you talk about the benefit? And this device has been in over 2,500 patients now. It's very safe. It's as safe as a dialysis procedure. So when you have a nice safety profile, you can move from the sickest patients in the intensive care unit, which is what we did for COVID.

So the most important thing that we kind of believe generically in medicine is what is the risk to the patient before you talk about the benefit? And this device has been in over 2,500 patients now. It's very safe. It's as safe as a dialysis procedure. So when you have a nice safety profile, you can move from the sickest patients in the intensive care unit, which is what we did for COVID.

And now we're moving into outpatients who have cancer, who have long COVID, chronic viremia, chronic Lyme, et cetera. And we're now going to move exactly to where you're saying is, can we help people to treat the disease of aging? Yes. Okay. And I know people don't love calling aging a disease and I don't want to sort of get into the nomenclature, but for many people, it is a type of disease.

And now we're moving into outpatients who have cancer, who have long COVID, chronic viremia, chronic Lyme, et cetera. And we're now going to move exactly to where you're saying is, can we help people to treat the disease of aging? Yes. Okay. And I know people don't love calling aging a disease and I don't want to sort of get into the nomenclature, but for many people, it is a type of disease.

And now we're moving into outpatients who have cancer, who have long COVID, chronic viremia, chronic Lyme, et cetera. And we're now going to move exactly to where you're saying is, can we help people to treat the disease of aging? Yes. Okay. And I know people don't love calling aging a disease and I don't want to sort of get into the nomenclature, but for many people, it is a type of disease.

And I think that this is biochemically something we can actually start to get a handle on. So for long COVID, it's currently a described syndrome. If we can get spike protein levels in everybody, you can start saying, are you a spike protein positive long COVID or not? And that helps us with diagnosis and with treatment decision-making.

And I think that this is biochemically something we can actually start to get a handle on. So for long COVID, it's currently a described syndrome. If we can get spike protein levels in everybody, you can start saying, are you a spike protein positive long COVID or not? And that helps us with diagnosis and with treatment decision-making.

And I think that this is biochemically something we can actually start to get a handle on. So for long COVID, it's currently a described syndrome. If we can get spike protein levels in everybody, you can start saying, are you a spike protein positive long COVID or not? And that helps us with diagnosis and with treatment decision-making.

I think for aging, we're getting much better at being able to profile people. So I don't want to be in the position of use, not even just our device, other devices will come, other medications will come, We wanna get more sophisticated. And you have begun to do this, I know, in your practice, which is, well, I'm not just gonna give everybody everything. What is it that's ailing you?

I think for aging, we're getting much better at being able to profile people. So I don't want to be in the position of use, not even just our device, other devices will come, other medications will come, We wanna get more sophisticated. And you have begun to do this, I know, in your practice, which is, well, I'm not just gonna give everybody everything. What is it that's ailing you?

I think for aging, we're getting much better at being able to profile people. So I don't want to be in the position of use, not even just our device, other devices will come, other medications will come, We wanna get more sophisticated. And you have begun to do this, I know, in your practice, which is, well, I'm not just gonna give everybody everything. What is it that's ailing you?

And let's talk about what's potentially causing it. And for a person who's struggling or a person who wants to be optimized, Is oxidative stress their big problem? Are they going to benefit from a hydrogen type kind of therapy? Or is it something else? Are they dealing with other issues? Is it endocrine?

And let's talk about what's potentially causing it. And for a person who's struggling or a person who wants to be optimized, Is oxidative stress their big problem? Are they going to benefit from a hydrogen type kind of therapy? Or is it something else? Are they dealing with other issues? Is it endocrine?